Market Tracker

04/23 8:29am ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

3.48
Data as of Apr 22
 +0.20 / +6.10%
Today’s Change
2.75
Today|||52-Week Range
5.50
-13.43%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close3.28
Today’s open3.28
Day’s range-- - --
Volume276,507
Average volume (3 months)172,801
Market cap$74.4M
Dividend yield--
Data as of 04/22/2014

Growth & Valuation

Earnings growth (last year)+23.81%
Earnings growth (this year)+15.36%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,471.01%
P/E ratioNM
Price/Sales56.21
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
MSLIMerus Labs Internati...+0.08+5.44%
HSKAHeska Corp-0.04-0.34%
CPXXCelator Pharmaceutic...-0.19-6.86%
KBIOKaloBios Pharmaceuti...+0.12+4.80%
Data as of 04/22/2014

Financials

Next reporting dateMay 15, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$1.1M
Annual profit (last year)-$10.2M
Net profit margin-941.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts